Tag: Lynparza

ThiIrd Lynparza Indication in EU

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced the European Commission has approved Lynparza (olaparib) as a monotherapy ...

EU Advisors Recommend AstraZeneca and Merck’s Tablets

AstraZeneca and Merck, known as MSD outside the United States and Canada, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positi...

AZ and MSD’s Drug Delays Pancreatic Cancer Progression

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced positive results from the Phase III POLO trial. Results from the trial ...

Successful Trials of AstraZeneca’s Cancer and Anemia Drugs

British drugmaker AstraZeneca on Thursday said its ovarian cancer and anemia treatments met their goals in three separate late stage trials. The positive results provide a shot in the arm for the c...